SCHEMBL110267

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL15268324	1.00	MAPK1 (0.35)	MAPK1NR1H2CHRM2CHRM1CHRM3
	SCHEMBL14295524	0.85	—	—
	SCHEMBL111444	0.83	MAPK1 (0.32)	MAPK1
	SCHEMBL110272	0.83	—	—
	SCHEMBL2681913	0.83	—	—
	SCHEMBL15268355	0.83	—	—
	SCHEMBL15268354	0.83	—	—
	SCHEMBL15268386	0.83	—	—
	SCHEMBL15962037	0.83	POLB (0.31)	NR1H2
	SCHEMBL18675599	0.82	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 393 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.